News
15h
The Manila Times on MSNBiado climbs to No. 1 spot in money maker list
CARLO Biado made history as the first Filipino cue artist to seize two world 9-ball titles after conquering the World Pool ...
5d
The Manila Times on MSNBiado, Regalario in all-Filipino semis duel at World Pool Championship
A Filipino cue artist assured itself of at least a runner-up finish at the World Pool Championships in Jeddah, Saudi Arabia.
4d
The Manila Times on MSNPH bets shine in World Pool
A FILIPINO cue artist assured itself of at least a runner-up finish at the World Pool Championships in Jeddah, Saudi Arabia.
1d
The Manila Times on MSNWorld Pool 9-Ball king Carlo Biado climbs to No. 1 spot in money maker list
Carlo Biado made history as the first Filipino cue artist to seize two world 9-ball titles after conquering the World Pool ...
Analysts expect markets to stay range-bound in the near term, with earnings season and global cues likely to drive direction. Defensive positioning and selective stock picking may offer resilience ...
The periderm layers of plants form an outer protective barrier. If the periderm is broken, movement of the gases ethylene and oxygen triggers a healing process.
View the latest Cue Biopharma Inc. (CUE) stock price, news, historical charts, analyst ratings and financial information from WSJ.
Whether you're team martini or cosmos, or even just thrive on a good ol' old fashioned — we've got just the Summer styling cues to spruce up your wardrobe ...
“If we don’t take those cues, then we will get left behind. “The prime minister hasn’t understood the importance nor urgency of a direct meeting with President Trump.
JAKARTA – At least four people were dead and dozens unaccounted for on July 3 after a ferry sank on its way to the resort island of Bali, according to rescue authorities, who said 31 survivors ...
Markets End Marginally Higher, Global Cues & Tariff Worries Weigh On Sentiment Sensex and Nifty closed slightly higher amid weak global cues and tariff uncertainty. Investors remained cautious ...
Novartis closes on filings for oral BTK drug remibrutinib as a treatment for chronic spontaneous urticaria after reporting 52-week data.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results